Roger A. Kautz was not included as an author in the published article. The corrected Author Contributions Statement appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Author contributions
CH: Designed and conducted experiments. XM and VJ: Metabolite scale up and NMR experiments. JW: Conducted animal PK experiments and data analysis. SK, AZ, and MM: Synthesized compound for studies and metabolite M1 for confirmation. RK and DS: assisted in setting up the microcoil probe and troubleshooting. CH, XM, and JG: Analyzed data and wrote the manuscript. JG and AM: Principal investigators oversaw the project, provided lab resources, and edited the manuscript.
Summary
Keywords
metabolite identification, LC-MS, micro-coil NMR, Adamantyl metabolism, di-hydroxyl adamantyl metabolite, CYP3A4 metabolism, CB2 agonist, cannabinoid metabolism
Citation
Honrao C, Ma X, Kulkarni S, Joshi V, Malamas M, Zvonok A, Wood J, Kautz RA, Strand D, Guo JJ and Makriyannis A (2021) Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite. Front. Pharmacol. 12:630274. doi: 10.3389/fphar.2021.630274
Received
17 November 2020
Accepted
18 February 2021
Published
22 April 2021
Approved by
Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2021
Updates
Copyright
© 2021 Honrao, Ma, Kulkarni, Joshi, Malamas, Zvonok, Wood, Kautz, Strand, Guo and Makriyannis.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jason J Guo, j.guo@northeastern.edu; Alexandros Makriyannis, a.makriyannis@northeastern.edu
Deceased.
This article was submitted to Drug Metabolism and Transport, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.